AAAAI Foundation
Funding research that leads to the prevention and cure of asthma and allergic and immunologic disease
What We Do

Currently Funded Awards

During 2022, the AAAAI Foundation supported 12 Faculty Development Awards. The support for these multi-year awards is only possible through continued support from our donors. Consider making a gift today.

2022

Sergio E. Chiarella, MD
The AAAAI Foundation & Donald YM Leung, MD, PhD, FAAAAI, Faculty Development Award
“Investigation of Tmem178 as a Novel Endogenous Inhibitory Pathway in Asthma”
Mayo Clinic - Division of Allergic Diseases|
Award Term: July 2022 - June 2025

Jocelyn Farmer, MD, PhD
“Define Immune Correlates of a Protective Response to SARS-CoV-2 Vaccine in Patients with Humoral Immunodeficiency”
Massachusetts General Hospital
Award Term: July 2022 - June 2025

Hsi-en (John) Ho, MD
“Dissecting Differential Inflammatory Response to Microbial Translocation in Primary Antibody Deficiencies”
Icahn School of Medicine at Mount Sinai
Award Term: July 2022 - June 2025

Jessica W. Hui, MD
“The Role of Temperature on the Skin Barrier and the Development of Atopy”
National Jewish Health
Award Term: July 2022 - June 2025

2021


 

Derek Chu, MD, PhD
Title: “Tree Nut Allergen Thresholds, Biomarkers, and Methods of Desensitization - TITAN and TRADE studies”
Institution: McMaster University
$240,000 paid over 3 years
Award Term: July 2021 - June 2024

 

Torie Grant, MD
Title: “Allergen Exposure Reduction as a Disease-Modifying Strategy in Allergen-Sensitized Children with Asthma”
Institution: Johns Hopkins University
$240,000 paid over 3 years
Award Term: July 2021 - June 2024

 



 

Melanie Ruffner, MD, PhD
Title: “Investigation of the Role of STAT6 Signaling in Proton-Pump Inhibitor Response in Eosinophilic Esophagitis”
Institution: The Children's Hospital of Philadelphia
$240,000 paid over 3 years
Award Term: July 2021 - June 2024

 


Cosby Stone, MD, MPH
Title: “Defining the Key Epidemiologic and Immunogenetic Risk Features of True IgE Mediated Cephalosporin Allergy”
Institution: Vanderbilt University Medical Center
$240,000 paid over 3 years
Award Term: July 2021 - June 2024

 

2020


Mark Gorelik, MD

Project: Follistatin Like-1 Protein is a Modulator of Immune Response in Inflammatory Vasculitis
Columbia University School of Medicine
Award Term: July 2020 - June 2023

 


Onyinye I. Iweala, MD, PhD

Project: Glycolipids and Invariant Natural Killer T Cells in Alpha-gal Syndrome
The University of North Carolina at Chapel Hill
Award Term: July 2020 - June 2023

 


Michael G. Sherenian, MD

Project: The Role of Hemostasis in Atopic Dermatitis
Cincinnati Children's Hospital Medical Center
Award Term: July 2020 - June 2023

 


Jeffrey Wilson, MD, PhD

Project: Investigations into the Glycolipid form of the Mammalian Oligosaccharide Galactose-a-1,3-Galactose (a-Gal) as an Agent of IgE-mediated Delayed Anaphylaxis and Atherosclerosis
University of Virginia
Award Term: July 2020 - June 2023

 

 

Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK